News on Stem Cell Therapeutics Corp. from BioPortfolio.com http://www.BioPortfolio.com Consolidated Stem Cell Therapeutics Corp. news from BioPortfolio.com Tue, 09 Feb 2010 23:36:39 GMT en Stem Cell Therapeutics Corp. Announces the Third and Final Positi...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035342&HITNO=0&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536208733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035342&HITNO=0&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536208733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035496&HITNO=1&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035496&THISHREF=http://c.moreover.com/click/here.pl%3fz2536264024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035496&HITNO=1&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035496&THISHREF=http://c.moreover.com/click/here.pl%3fz2536264024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modifhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035388&HITNO=2&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035388&THISHREF=http://c.moreover.com/click/here.pl%3fz2536224271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035388&HITNO=2&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035388&THISHREF=http://c.moreover.com/click/here.pl%3fz2536224271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035125&HITNO=3&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035125&THISHREF=http://c.moreover.com/click/here.pl%3fz2536123236%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035125&HITNO=3&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035125&THISHREF=http://c.moreover.com/click/here.pl%3fz2536123236%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035115&HITNO=4&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035115&THISHREF=http://c.moreover.com/click/here.pl%3fz2536119602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035115&HITNO=4&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035115&THISHREF=http://c.moreover.com/click/here.pl%3fz2536119602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035936&HITNO=5&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035936&THISHREF=http://c.moreover.com/click/here.pl%3fz2536429089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035936&HITNO=5&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035936&THISHREF=http://c.moreover.com/click/here.pl%3fz2536429089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035642&HITNO=6&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035642&THISHREF=http://c.moreover.com/click/here.pl%3fz2536313111%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035642&HITNO=6&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035642&THISHREF=http://c.moreover.com/click/here.pl%3fz2536313111%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Stem Cell completes safety review of Regenesishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035873&HITNO=7&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035873&THISHREF=http://c.moreover.com/click/here.pl%3fz2536410860%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035873&HITNO=7&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035873&THISHREF=http://c.moreover.com/click/here.pl%3fz2536410860%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035747&HITNO=8&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035747&THISHREF=http://c.moreover.com/click/here.pl%3fz2536354467%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035747&HITNO=8&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035747&THISHREF=http://c.moreover.com/click/here.pl%3fz2536354467%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035746&HITNO=9&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035746&THISHREF=http://c.moreover.com/click/here.pl%3fz2536354014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035746&HITNO=9&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035746&THISHREF=http://c.moreover.com/click/here.pl%3fz2536354014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035739&HITNO=10&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035739&THISHREF=http://c.moreover.com/click/here.pl%3fz2536350950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035739&HITNO=10&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035739&THISHREF=http://c.moreover.com/click/here.pl%3fz2536350950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035737&HITNO=11&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035737&THISHREF=http://c.moreover.com/click/here.pl%3fz2536350523%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035737&HITNO=11&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035737&THISHREF=http://c.moreover.com/click/here.pl%3fz2536350523%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035385&HITNO=12&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035385&THISHREF=http://c.moreover.com/click/here.pl%3fz2536223106%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035385&HITNO=12&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035385&THISHREF=http://c.moreover.com/click/here.pl%3fz2536223106%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035028&HITNO=13&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035028&THISHREF=http://c.moreover.com/click/here.pl%3fz2536092537%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035028&HITNO=13&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035028&THISHREF=http://c.moreover.com/click/here.pl%3fz2536092537%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockHouse USA: Updates for PPD (Nasdaq:PPDI), Repros Therapeutics (Nasdaq:RPRX), Stem Cell Therapy (OTC:SCII)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035374&HITNO=14&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035374&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035374&HITNO=14&MSIZE=570&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Stem%20Cell%20Therapeutics%20Corp.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035374&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: